August 05, 2020
A Delaware federal judge on Wednesday upheld two patents held by Bristol-Myers Squibb, one jointly with Pfizer, that underlie their anticoagulant medication Eliquis, ruling that proposed drugs from Sigmapharm, Sunshine Lake Pharma and Unichem Laboratories infringe one or both of the patents.